Xenetic Biosciences, Inc.
XBIO· Nasdaq
XBIOXenetic Biosciences, Inc.
Filed Mar 29, 2019 · 10-K · 88 days after period end · 0001683168-19-000840
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$1.64M | $4.45M | -$391.33K | -$3.63M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Mar 29, 2019 · 88 d after period end
